Dr. Joel Lavine is a pediatrician who has dedicated his life to researching and treating NASH, a type of liver disease that affects millions of children and adults in the United States. Dr. Lavine joined a team of seven other investigators, and was the only pediatric investigator who was supported by the National Institutes of Diabetes, Kidney, and Digestive Diseases, also known as NIDDK, in the NASH Clinical Research Network. He served as co-chair of the NASH CRN Steering Committee for 16 years, chair of the Pediatric Committee, and co-chair of the Data Base Committee. In this role, he authored nearly all of the protocols related to pediatric studies conducted by the consortium and is currently involved with major clinical trials performed in adults and published in prestigious journals such as The New England Journal and Lancet.